Related Experiment Videos
Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in
Jianfeng Wu1, Qunxi Dong1,2, Jie Gui3
1School of Computing, Informatics, and Decision Systems Engineering, Arizona State University, Tempe, AZ, United States.
Frontiers in Neuroscience
|August 23, 2021
Summary
This study introduces a novel MRI-based method using Patch Analysis-based Surface Correntropy-induced Sparse-coding and Max-Pooling (PASCS-MP) to detect beta-amyloid (Aβ) in Alzheimer's disease (AD). The method shows high accuracy in identifying Aβ positivity in both mild cognitive impairment and cognitively unimpaired individuals.
Area of Science:
- Neuroimaging
- Biomarker Discovery
- Alzheimer's Disease Research
Background:
- Early detection of Alzheimer's disease (AD) is crucial for therapeutic intervention.
- Beta-amyloid (Aβ) plaque accumulation is an early hallmark of AD.
- Current Aβ detection methods are invasive or costly.
Purpose of the Study:
- To develop a non-invasive method for inferring brain Aβ burden at the individual level using MRI.
- To utilize multivariate morphometry statistics (MMS) of the hippocampus for Aβ detection.
- To introduce a novel sparse coding algorithm, PASCS-MP, for low-dimensional representation of hippocampal data.
Main Methods:
- Applied MRI-based hippocampal multivariate morphometry statistics (MMS).
- Developed and employed a sparse coding algorithm, Patch Analysis-based Surface Correntropy-induced Sparse-coding and Max-Pooling (PASCS-MP), for data representation.
- Utilized a binary random forest classifier to predict Aβ positivity in two independent cohorts (ADNI and OASIS).
Main Results:
- The PASCS-MP method achieved high accuracy in discriminating Aβ positivity.
- Accuracy was 0.89 in mild cognitive impairment (MCI) individuals (ADNI).
- Accuracy was 0.79 (ADNI) and 0.81 (OASIS) in cognitively unimpaired (CU) individuals.
Conclusions:
- The proposed MRI-MMS and PASCS-MP method offers a promising non-invasive approach for detecting brain Aβ burden.
- This method demonstrates superior performance compared to traditional algorithms for Aβ detection.
- The findings support the potential of MRI-MMS as a cost-effective biomarker for early AD detection.